What is ResMed?
Founded in 1989, ResMed is a global leader in the development, manufacturing, and marketing of innovative medical products. The company's primary focus is on the treatment and management of respiratory disorders, with a specialized emphasis on sleep-disordered breathing. ResMed's commitment to advancing healthcare solutions positions it as a key player in the medical device industry, leveraging technology to improve patient outcomes and quality of life.
How much funding has ResMed raised?
ResMed has raised a total of $18.9M across 1 funding round:
Stock Offering
$18.9M
Stock Issuance/Offering (1995): $18.9M, investors not publicly disclosed
What's next for ResMed?
The substantial enterprise-level funding context suggests ResMed is in a mature growth phase, likely focusing on scaling operations, expanding its product portfolio, and potentially pursuing strategic acquisitions. Continued investment in research and development for respiratory and sleep-disordered breathing treatments will be crucial for maintaining its market leadership and addressing the growing global demand for effective healthcare solutions.
See full ResMed company page
